| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 310,522 | 292,040 | 271,827 | 320,617 | | Cost of Revenue | 245,786 | 237,898 | 234,139 | 267,636 | | | Gross Profit | 64,736 | 54,142 | 37,688 | 52,981 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,064 | 27,331 | 26,169 | 33,100 | | Non Recurring | 457 | 300 | 19,984 | (3,048) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,215 | 26,511 | (8,465) | 22,929 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,469 | 2,074 | 2,850 | 3,586 | | Earnings Before Interest And Taxes | 39,684 | 28,585 | (5,615) | 26,515 | | Interest Expense | 27 | 20 | 12 |
-
| | Income Before Tax | 39,657 | 28,565 | (5,627) | 26,515 | | Income Tax Expense | 8,015 | 4,285 | (3,813) | 2,651 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 31,642 | 24,280 | (1,814) | 23,864 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 31,642 | 24,280 | (1,814) | 23,864 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $31,642 | $24,280 | ($1,814) | $23,864 |
|
0.11% Nasdaq 
0.01%
Income Statement
